Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mohamed El Missiry (Satu Mustjoki, S Mustjoki, Satu M Mustjoki)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 49

Top Venues

Leukemia

Blood

Nature communications

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, Dipabarna Bhattacharya, Petrus Järvinen, Sara Tornberg, Harry Nísen, Tuomas Mirtti, Ilona Uski, Anita Kumari, Karita Peltonen, Arianna Draghi, Marco Donia, Anna Kreutzman, Mohamed El Missiry
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma. Cancer research communications 3 (7) (2023)
Otso Brummer, Petri Pölönen, Mohamed El Missiry, Oscar Brück
Computational textural mapping harmonises sampling variation and reveals multidimensional histopathological fingerprints. British journal of cancer (2023)
Tania Brandstoetter, Johannes Schmoellerl, Reinhard Grausenburger, Sebastian Kollmann, Eszter Doma, Jani Huuhtanen, Thorsten Klampfl, Thomas Eder, Florian Grebien, Gregor Hoermann, Johannes Zuber, Mohamed El Missiry, Barbara Maurer, Veronika Sexl
SBNO2 is a critical mediator of STAT3-driven hematological malignancies. Blood (2023)
Monika Dolinska, Huan Cai, Alma Mansson, Jingyi Shen, Pingnan Xiao, Thibault Bouderlique, Xidan Li, Elory Leonard, Marcus Chang, Yuchen Gao, Juan Pablo Medina Giménez, Makoto Kondo, Lakshmi Sandhow, Anne-Sofie Johansson, Stefan Deneberg, Stina Söderlund, Martin Jädersten, Johanna S Ungerstedt, Magnus Tobiasson, Arne Östman, Mohamed El Missiry, Leif Stenke, Katarina Le Blanc, Eva S Hellstrom-Lindberg, Sören Lehmann, Marja Ekblom, Ulla Olsson-Strömberg, Mikael Sigvardsson, Hong Qian
Characterization of Bone Marrow Niche in Chronic Myeloid Leukemia Patients Identifies CXCL14 as a New Therapeutic Option. Blood (2023)
Tania Brandstoetter, Johannes Schmoellerl, Reinhard Grausenburger, Sebastian Kollmann, Eszter Doma, Jani Huuhtanen, Thorsten Klampfl, Thomas Eder, Florian Grebien, Gregor Hoermann, Johannes Zuber, Mohamed El Missiry, Barbara Maurer, Veronika Sexl
SBNO2 is a critical mediator of STAT3-driven hematological malignancies. Blood (2023)
Jani Huuhtanen, Shady Adnan-Awad, Jason Theodoropoulos, Sofia Forstén, Rebecca Warfvinge, Olli Dufva, Jonas Otto Vilhelm Bouhlal, Parashar Dhapola, Hanna Duàn, Essi Laajala, Tiina Kasanen, Jay Klievink, Mette Ilander, Taina Jaatinen, Ulla Olsson-Strömberg, Henrik Hjorth-Hansen, Andreas Burchert, Göran Karlsson, Anna Kreutzman, Harri Lähdesmäki, Mohamed El Missiry
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation. Leukemia (2023)
Heikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela, Aino-Maija Leppä, Jani Huuhtanen, Ida Maria Vänttinen, Petra Johanna Nygren, Jay Klievink, Jonas Otto Vilhelm Bouhlal, Petri Pölönen, Qi Zhang, Shady Adnan-Awad, Cristina Mancebo-Pérez, Joseph Saad, Juho J Miettinen, Komal Kumar Javarappa, Sofia Aakko, Tanja Ruokoranta, Samuli Eldfors, Merja Heinäniemi, Kim Theilgaard-Mönch, Ulla Wartiovaara-Kautto, Mikko A I Keränen, Kimmo Porkka, Marina Konopleva, Krister Wennerberg, Mika Kontro, Caroline A Heckman, Mohamed El Missiry
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia. Blood (2022)
Tiina Kelkka, Mikko Tyster, Sofie A Lundgren, Xingmin Feng, Cassandra Kerr, Kohei Hosokawa, Jani Huuhtanen, Mikko Keränen, Bhavisha Patel, Toru Kawakami, Yuka Maeda, Otso Nieminen, Tiina Kasanen, Pasi Aronen, Bhagwan Yadav, Hanna Rajala, Hideyuki Nakazawa, Taina Jaatinen, Eva Hellström-Lindberg, Seishi Ogawa, Fumihiro Kawakami, Hiroyoshi Nishikawa, Shinji Nakao, Jaroslaw P Maciejewski, Neal S Young, Mohamed El Missiry
Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia. Leukemia 36 (9) (2022)
Jani Huuhtanen, Liang Chen, Emmi Jokinen, Henna Kasanen, Tapio Lönnberg, Anna Kreutzman, Katriina Peltola, Micaela Hernberg, Chunlin Wang, Cassian Yee, Harri Lähdesmäki, Mark M Davis, Mohamed El Missiry
Evolution and modulation of antigen-specific T cell responses in melanoma patients. Nature communications 13 (1) (2022)
Moon Hee Lee, Petrus Järvinen, Harry Nísen, Oscar Brück, Mette Ilander, Ilona Uski, Jason Theodoropoulos, Matti Kankainen, Tuomas Mirtti, Mohamed El Missiry, Anna Kreutzman
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. Oncoimmunology 11 (1) (2022)
Heikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela, Aino-Maija Leppä, Jani Huuhtanen, Ida Maria Vänttinen, Petra Johanna Nygren, Jay Klievink, Jonas Otto Vilhelm Bouhlal, Petri Pölönen, Qi Zhang, Shady Adnan-Awad, Cristina Mancebo-Pérez, Joseph Saad, Juho J Miettinen, Komal Kumar Javarappa, Sofia Aakko, Tanja Ruokoranta, Samuli Eldfors, Merja Heinäniemi, Kim Theilgaard-Mönch, Ulla Wartiovaara-Kautto, Mikko A I Keränen, Kimmo Porkka, Marina Konopleva, Krister Wennerberg, Mika Kontro, Caroline A Heckman, Mohamed El Missiry
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia. Blood (2022)
Harsimran Kaur Garcha, Nabanita Nawar, Helena Sorger, Fettah Erdogan, Myint Myat Khine Aung, Abootaleb Sedighi, Pimyupa Manaswiyoungkul, Hyuk-Soo Seo, Susann Schönefeldt, Daniel Pölöske, Sirano Dhe-Paganon, Heidi A Neubauer, Mohamed El Missiry, Marco Herling, Elvin D de Araujo, Richard Moriggl, Patrick T Gunning
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Shady Adnan-Awad, Oscar Brück, Naranie Shanmuganathan, Timo Jarvinen, Hanna Lähteenmäki, Jay Klievink, Hazem Ibrahim, Soili Kytölä, Perttu Koskenvesa, Timothy P Hughes, Susan Branford, Matti Kankainen, Mohamed El Missiry
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation. Blood cancer journal 12 (4) (2022)
Jani Huuhtanen, Dipabarna Bhattacharya, Tapio Lönnberg, Matti Kankainen, Cassandra Kerr, Jason Theodoropoulos, Hanna L M Rajala, Carmelo Gurnari, Tiina Kasanen, Till Braun, Antonella Teramo, Renato Zambello, Marco Herling, Fumihiro Kawakami, Toru Kawakami, Marko Salmi, Thomas Loughran, Jaroslaw P Maciejewski, Harri Lähdesmäki, Tiina Kelkka, Mohamed El Missiry
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8 + T-cell large granular lymphocytic leukemia. Nature communications 13 (1) (2022)
Firas Hamdan, Erkko O Ylösmäki, Jacopo Chiaro, Yvonne Giannoula, Maeve Long, Manlio Fusciello, Sara Feola, Beatriz Martins, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Otto Kari, Moon Lee, Petrus Järvinen, Harry Nisen, Anna Kreutzman, Jeanette H W Leusen, Mohamed El Missiry, Thomas G McWilliams, Mikaela Grönholm, Vincenzo Cerullo
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids. Journal for immunotherapy of cancer 9 (8) (2022)
Dipabarna Bhattacharya, Antonella Teramo, Vanessa Rebecca Gasparini, Jani Huuhtanen, Daehong Kim, Jason Theodoropoulos, Gianluca Schiavoni, Gregorio Barilà, Cristina Vicenzetto, Giulia Calabretto, Monica Facco, Toru Kawakami, Hideyuki Nakazawa, Brunangelo Falini, Enrico Tiacci, Fumihiro Ishida, Gianpietro C Semenzato, Tiina Kelkka, Renato Zambello, Mohamed El Missiry
Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia. Blood cancer journal 12 (2) (2022)
Simona Pagliuca, Carmelo Gurnari, Hassan Awada, Ashwin Kishtagari, Sunisa Kongkiatkamon, Laila Terkawi, Misam Zawit, Yihong Guan, Thomas LaFramboise, Babal Kant Jha, Bhumika J Patel, Betty K Hamilton, Navneet S Majhail, Sofie A Lundgren, Mohamed El Missiry, Yogen Saunthararajah, Valeria Visconte, Timothy Chan, Chao-Yie Yang, Tobias Lenz, Jaroslaw P Maciejewski
The Similarity of Class II HLA Genotypes Defines Patterns of Autoreactivity in Idiopathic Bone Marrow Failure Disorders. Blood (2021)
Susann Schönefeldt, Tamara Wais, Marco Herling, Mohamed El Missiry, Vasileios Bekiaris, Richard Moriggl, Heidi A Neubauer
The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma. Cancers 13 (24) (2021)
Emmi Jokinen, Jani Huuhtanen, Mohamed El Missiry, Markus Heinonen, Harri Lähdesmäki
Predicting recognition between T cell receptors and epitopes with TCRGP. PLoS computational biology 17 (3) (2021)
Oscar Brück, Moon Hee Lee, Riku Turkki, Ilona Uski, Patrick Penttilä, Lassi Paavolainen, Panu Kovanen, Petrus Järvinen, Petri Bono, Teijo Pellinen, Mohamed El Missiry, Anna Kreutzman
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (12) (2021)
Michal Sheffer, Emily Lowry, Nicky Beelen, Minasri Borah, Suha Naffar-Abu Amara, Chris C Mader, Jennifer A Roth, Aviad Tsherniak, Samuel S Freeman, Olga Dashevsky, Sara Gandolfi, Samantha Bender, Jordan G Bryan, Cong Zhu, Li Wang, Ifrah Tariq, Govinda M Kamath, Ricardo De Matos Simoes, Eugen Dhimolea, Channing Yu, Yiguo Hu, Olli Dufva, Marios Giannakis, Vasilis Syrgkanis, Ernest Fraenkel, Todd R Golub, Rizwan Romee, Mohamed El Missiry, Aedin C Culhane, Lotte Wieten, Constantine S Mitsiades
Genome-scale screens identify factors regulating tumor cell responses to natural killer cells. Nature genetics 53 (8) (2021)
Joaquin Martinez Lopez, Mohamed El Missiry, Kimmo Porkka, Rebecca B Klisovic, Dominik Wolf, Lambert Busque, Juan Carlos Carlos Hernández-Boluda, Rene Swanink, Patricia Martin Regueira, Jeffrey H Lipton
The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study. Leukemia & lymphoma 62 (8) (2021)
Jacopo Chiaro, Henna H E Kasanen, Thomas Whalley, Cristian Capasso, Mikaela Grönholm, Sara Feola, Karita Peltonen, Firas Hamdan, Micaela M Hernberg, Siru Mäkelä, Hanna Karhapää, Paul E Brown, Beatriz Martins, Manlio Fusciello, Erkko O Ylösmäki, Dario Greco, Anna S Kreutzman, Mohamed El Missiry, Barbara Szomolay, Vincenzo Cerullo
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma. Cancer immunology research 9 (8) (2021)
Disha Malani, Ashwini Kumar, Oscar Bruck, Mika Kontro, Bhagwan Yadav, Monica Hellesøy, Heikki Kuusanmaki, Olli Dufva, Matti Kankainen, Samuli Eldfors, Swapnil Potdar, Jani Saarela, Laura Turunen, Alun Parsons, Imre Vastrik, Katja Kivinen, Janna Saarela, Riikka Raty, Minna Lehto, Maija Wolf, Bjorn Tore Gjertsen, Mohamed El Missiry, Tero Aittokallio, Krister Wennerberg, Caroline A Heckman, Olli Kallioniemi, Kimmo Porkka
Implementing a functional precision medicine tumor board for acute myeloid leukemia. Cancer discovery (2021)
Shady Adnan-Awad, Matti Kankainen, Mohamed El Missiry
Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia. Leukemia & lymphoma 62 (9) (2021)
Daehong Kim, Giljun Park, Jani Huuhtanen, Bishwa R Ghimire, Hanna Rajala, Richard Moriggl, Wing C Chan, Matti Kankainen, Mikko Myllymäki, Mohamed El Missiry
STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation. Leukemia 35 (12) (2021)
Mohamed El Missiry, Neal S Young
Somatic Mutations in "Benign" Disease. The New England journal of medicine 384 (21) (2021)
Sofie A Lundgren, Mikko A I Keränen, Matti Kankainen, Jani Huuhtanen, Gunilla Walldin, Cassandra M Kerr, Michael Clemente, Freja Ebeling, Hanna Rajala, Oscar Brück, Harri Lähdesmäki, Sari Hannula, Tiina Hannunen, Pekka Ellonen, Neal S Young, Seishi Ogawa, Jaroslaw P Maciejewski, Eva Hellström-Lindberg, Mohamed El Missiry
Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia. Leukemia 35 (5) (2021)
S Pützer, L Varghese, J von Jan, T Braun, A K Giri, P Mayer, N Riet, S Timonen, S Oberbeck, H Kuusanmäki, Mohamed El Missiry, Marc-Henri Stern, Tero Aittokallio, S Newrzela, A Schrader, M Herling
Corrections: Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine. Leukemia (2020)
Shady Adnan-Awad, Olli Dufva, Aleksandr Ianevski, Bishwa R Ghimire, Jan Koski, Pilvi Maliniemi, Daniel Thomson, Andreas Schreiber, Caroline A Heckman, Perttu Koskenvesa, Matti Korhonen, Kimmo Porkka, Susan Branford, Tero Aittokallio, Matti Kankainen, Mohamed El Missiry
RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses. Leukemia 35 (4) (2020)
Henna Kasanen, Micaela M Hernberg, Siru Mäkelä, Oscar Brück, Susanna Juteau, Laura Kohtamäki, Mette Ilander, Mohamed El Missiry, Anna Kreutzman
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients. Cancer immunology, immunotherapy : CII 69 (5) (2020)
Cassandra M Kerr, Michael J Clemente, Peter W Chomczynski, Bartlomiej Przychodzen, Yasunobu Nagata, Vera Adema, Valeria Visconte, Alan E Lichtin, Mohamed El Missiry, Tomas Radivoyevitch, Mikkael A Sekeres, Jaroslaw P Maciejewski
Subclonal STAT3 mutations solidify clonal dominance. Blood advances 3 (6) (2020)
Emma I Andersson, Oscar Brück, Marco Herling, Susanna Mannisto, Leena Saikko, Sonja Lagström, Pekka Ellonen, Sirpa Leppä, Marco Herling, Panu E Kovanen, Mohamed El Missiry
STAT3 Mutation Is Associated with STAT3 Activation in CD30+ ALK- ALCL. Cancers 12 (3) (2020)
Daehong Kim, Giljun Park, Jani Huuhtanen, Sofie Lundgren, Rajiv K Khajuria, Ana María Hurtado López, Cecilia Muñoz-Calleja, Laura Cardeñoso, Valle Gómez-García de Soria, Tzu Hua Chen-Liang, Samuli Eldfors, Pekka Ellonen, Sari Hannula, Matti Kankainen, Oscar Brück, Anna Kreutzman, Urpu Salmenniemi, Tapio Lönnberg, Andrés Jerez, Maija Itälä-Remes, Mikko Myllymäki, Mikko A I Keränen, Mohamed El Missiry
Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease. Nature communications 11 (1) (2020)
Vanessa Rebecca Gasparini, Andrea Binatti, Alessandro Coppe, Antonella Teramo, Cristina Vicenzetto, Giulia Calabretto, Gregorio Barilà, Annica Barizza, Edoardo Giussani, Monica Facco, Mohamed El Missiry, Gianpietro C Semenzato, Renato Zambello, Stefania Bortoluzzi
A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells. Blood cancer journal 10 (4) (2020)
S Pützer, L Varghese, J von Jan, T Braun, A K Giri, P Mayer, N Riet, S Timonen, S Oberbeck, H Kuusanmäki, Mohamed El Missiry, Marc-Henri Stern, Tero Aittokallio, S Newrzela, A Schrader, M Herling
Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine. Leukemia 34 (9) (2020)
Shady Adnan-Awad, Daehong Kim, Helena Hohtari, Komal Kumar Javarappa, Tania Brandstoetter, Isabella Mayer, Swapnil Potdar, Caroline A Heckman, Soili Kytölä, Kimmo Porkka, Eszter Doma, Veronika Sexl, Matti Kankainen, Mohamed El Missiry
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. Leukemia 35 (7) (2020)
Kristiina Karihtala, Suvi-Katri Leivonen, Oscar Brück, Marja-Liisa Karjalainen-Lindsberg, Mohamed El Missiry, Teijo Pellinen, Sirpa Leppa
Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma. Cancers 12 (4) (2020)
Susan Branford, Dennis Dong Hwan Kim, Jane F Apperley, Christopher A Eide, Mohamed El Missiry, S Tiong Ong, Georgios Nteliopoulos, Thomas Ernst, Charles Chuah, Carlo B Gambacorti-Passerini, Michael J Mauro, Brian J Druker, Dong-Wook Kim, Francois-Xavier Mahon, Jorge Cortes, Jerry P Radich, Andreas Hochhaus, Timothy P Hughes, null null
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia. Leukemia 33 (8) (2019)
Heidi M Haikala, Johanna M Anttila, Elsa Marques, Tiina Raatikainen, Mette Ilander, Henna Hakanen, Hanna Ala-Hongisto, Mariel Savelius, Diego Balboa, Björn von Eyss, Vilja Eskelinen, Pauliina Munne, Anni I Nieminen, Timo Otonkoski, Julia Schüler, Teemu D Laajala, Tero Aittokallio, Harri Jaakko Sihto, Johanna Mattson, Päivi Heikkilä, Marjut Leidenius, Heikki Joensuu, Mohamed El Missiry, Panu Kovanen, Martin Eilers, Joel D Leverson, Juha Klefström
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nature communications 10 (1) (2019)
Heidi M Haikala, Johanna M Anttila, Elsa Marques, Tiina Raatikainen, Mette Ilander, Henna Hakanen, Hanna Ala-Hongisto, Mariel Savelius, Diego Balboa, Björn von Eyss, Vilja Eskelinen, Pauliina Munne, Anni I Nieminen, Timo Otonkoski, Julia Schüler, Teemu D Laajala, Tero Aittokallio, Harri Jaakko Sihto, Johanna Mattson, Päivi Heikkilä, Marjut Leidenius, Heikki Joensuu, Mohamed El Missiry, Panu Kovanen, Martin Eilers, Joel D Leverson, Juha Klefström
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nature communications 10 (1) (2019)
Helena Hohtari, Oscar Brück, Sami Blom, Riku Turkki, Marjatta Sinisalo, Panu E Kovanen, Olli Kallioniemi, Teijo Pellinen, Kimmo Porkka, Mohamed El Missiry
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL. Leukemia 33 (7) (2019)
Anna Kreutzman, Bhagwan Yadav, Tim H Brummendorf, Bjorn Tore Gjertsen, Moon Hee Lee, Jeroen Janssen, Tiina Kasanen, Perttu Koskenvesa, Kourosh Lotfi, Berit Markevärn, Ulla Olsson-Strömberg, Jesper Stentoft, Leif Stenke, Stina Söderlund, Lene Udby, Johan Richter, Henrik Hjorth-Hansen, Mohamed El Missiry
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. Oncoimmunology 8 (9) (2019)
Mohamed El Missiry
Non-Ph variants in CML: guilty drivers? Blood 132 (9) (2019)
Sebastian Kollmann, Eva Grundschober, Barbara Maurer, Wolfgang Warsch, Reinhard Grausenburger, Leo Edlinger, Jani Huuhtanen, Sabine Lagger, Lothar Hennighausen, Peter Valent, Thomas Decker, Birgit Strobl, Mathias Mueller, Mohamed El Missiry, Andrea Hoelbl-Kovacic, Veronika Sexl
Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia. Leukemia 33 (7) (2019)
Olli Dufva, Matti Kankainen, Tiina Kelkka, Nodoka Sekiguchi, Shady Adnan Awad, Samuli Eldfors, Bhagwan Yadav, Heikki Kuusanmäki, Disha Malani, Emma I Andersson, Paavo Pietarinen, Leena Saikko, Panu E Kovanen, Teija Ojala, Dean A Lee, Thomas P Loughran, Hideyuki Nakazawa, Junji Suzumiya, Ritsuro Suzuki, Young-Hyeh Ko, Won Seog Kim, Shih-Sung Chuang, Tero Aittokallio, Wing C Chan, Koichi Ohshima, Fumihiro Ishida, Mohamed El Missiry
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target. Nature communications 9 (1) (2018)
Tilman Schneider-Hohendorf, Dennis Görlich, Paula Savola, Tiina Kelkka, Mohamed El Missiry, Catharina C Gross, Geoffrey C Owens, Luisa Klotz, Klaus Dornmair, Heinz Wiendl, Nicholas Schwab
Sex bias in MHC I-associated shaping of the adaptive immune system. Proceedings of the National Academy of Sciences of the United States of America 115 (9) (2018)
Mohamed El Missiry, Henrik Hjorth-Hansen, Johan Richter, Ulla Olson-Strömberg, Leif Stenke, Kimmo Porkka, Anna Kreutzman, Satu Mustjoki
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia. PloS one 12 (1) (2017)
Emma I Andersson, Takahiro Tanahashi, Nodoka Sekiguchi, Vanessa Rebecca Gasparini, Sabrina Bortoluzzi, Toru Kawakami, Kazuyuki Matsuda, Takeki Mitsui, Samuli Eldfors, Stefania Bortoluzzi, Alessandro Coppe, Andrea Binatti, Sonja Lagström, Pekka Ellonen, Noriyasu Fukushima, Sayaka Nishina, Noriko Senoo, Hitoshi Sakai, Hideyuki Nakazawa, Yok-Lam Kwong, Thomas P Loughran, Jaroslaw P Maciejewski, Mohamed El Missiry, Fumihiro Ishida
High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia. Blood 128 (20) (2016)

Mohamed El Missiry.css-eqlu8i{font-size:small;padding-left:4px;} (Satu Mustjoki, S Mustjoki, Satu M Mustjoki)

Publication Activity (10 Years)

Top Topics

Top Venues

Mohamed El Missiry (Satu Mustjoki, S Mustjoki, Satu M Mustjoki)